InvestorsHub Logo

traderwil

04/24/17 11:05 AM

#7125 RE: lawomen21 #7124

I looked at a few other hemp companies that are also down today. These young companies trading OTC like VATE with little reported revenue and negative cash flow from operations are overpriced in my opinion. Until we see VATE's Q1 financials, the price is just trading on optimism for the future of hemp. Down around $0.01 would be a buying opportunity for me until I see current revenue, expense, and debt numbers (or some really tempting news).